During first outburst of COVID‐19, several strategies had been applied for surgical oncology patients to minimize COVID‐19 transmission. COVID‐19 infection seemed to compromise survival and major complication rates of surgical… Click to show full abstract
During first outburst of COVID‐19, several strategies had been applied for surgical oncology patients to minimize COVID‐19 transmission. COVID‐19 infection seemed to compromise survival and major complication rates of surgical oncology patients. However, survival, tumor progression and recurrence rates of surgical oncology patients were associated to the consequences of COVID‐19 pandemic on their management. In addition, the severity of COVID‐19 infections has been downgraded. Therefore, management of surgical oncology patients should be reconsidered.
               
Click one of the above tabs to view related content.